Matched placebo for the IMP, LTG-001 tablet clinical trials

A Phase 2, Randomized, Double-blind, Placebo-controlled Crossover Study Evaluating the Efficacy and Safety of LTG-001 in Patients with Osteoarthritis of the Knee

This study is testing a new tablet, LTG-001, for knee osteoarthritis. We want to see if it helps reduce pain and if it's safe to use. Some participants will get the new tablet, and others a dummy tablet, at different times.